MD-Bio is a leader in innovative diagnostic solutions, specializing in harm reduction test kits for Fentanyl and Xylazine detection, as well as advanced diagnostics for biothreats and emerging diseases. By combining cutting-edge technology with practical, field-ready tools, MD-Bio is at the forefront of safeguarding public health. From combating the opioid crisis to detecting critical pathogens, MD-Bio delivers reliable, accessible solutions that empower communities, healthcare providers, and first responders. Dedicated to innovation and impact, MD-Bio strives to protect lives and address the evolving challenges of global health.

MD-Bio

Org chart

Teams

Offices